Synthesis and Biological Evaluation of New Eugenol Mannich Bases as Promising Antifungal Agents

New Mannich base‐type eugenol derivatives were synthesized and evaluated for their anticandidal activity using a broth microdilution assay. Among the synthesized compounds, 4‐allyl‐2‐methoxy‐6‐(morpholin‐4‐ylmethyl) phenyl benzoate (7) and 4‐{5‐allyl‐2‐[(4‐chlorobenzoyl)oxy]‐3‐methoxybenzyl}morpholi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemical biology & drug design 2015-10, Vol.86 (4), p.459-465
Hauptverfasser: Abrão, Pedro Henrique O., Pizi, Rafael B., de Souza, Thiago B., Silva, Naiara C., Fregnan, Antonio M., Silva, Fernanda N., Coelho, Luiz Felipe L., Malaquias, Luiz Cosme C., Dias, Amanda Latercia T., Dias, Danielle F., Veloso, Marcia P., Carvalho, Diogo T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 465
container_issue 4
container_start_page 459
container_title Chemical biology & drug design
container_volume 86
creator Abrão, Pedro Henrique O.
Pizi, Rafael B.
de Souza, Thiago B.
Silva, Naiara C.
Fregnan, Antonio M.
Silva, Fernanda N.
Coelho, Luiz Felipe L.
Malaquias, Luiz Cosme C.
Dias, Amanda Latercia T.
Dias, Danielle F.
Veloso, Marcia P.
Carvalho, Diogo T.
description New Mannich base‐type eugenol derivatives were synthesized and evaluated for their anticandidal activity using a broth microdilution assay. Among the synthesized compounds, 4‐allyl‐2‐methoxy‐6‐(morpholin‐4‐ylmethyl) phenyl benzoate (7) and 4‐{5‐allyl‐2‐[(4‐chlorobenzoyl)oxy]‐3‐methoxybenzyl}morpholin‐4‐ium chloride (8) were found to be the most effective antifungal compounds with low IC50 values, some of them well below those of reference drug fluconazole. The most significant IC50 values were those of 7 against C. glabrata (1.23 μm), C. albicans and C. krusei (both 0.63 μm). Additionally, the synthesized compounds were evaluated for their in vitro cytotoxic effects on human mononuclear cells. As result, the cytotoxic activity of eugenol in eukaryotic cells decreased with the introduction of the morpholinyl group. Given these findings, we point out compounds 7 and 8 as the most promising derivatives because they showed potency values greater than those of eugenol and fluconazole and they also presented high selectivity indexes. A series of new eugenol derivatives was synthesized and evaluated for its anticandidal activities. The morpholinyl Mannich base 7 (4‐allyl‐2‐methoxy‐6‐(morpholin‐4‐ylmethyl) phenyl benzoate) showed high antifungal activity (IC50 0.63 μm) and an expressive selectivity index (600.0) against Candida albicans and Candida krusei.
doi_str_mv 10.1111/cbdd.12504
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1718077416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1718077416</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3674-7a677ad3f09a524565497f659d54fe47eb1c0b106ba72d3c84f749b824e0cdfa3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0E4r3hA5CXCClgJ7YnWbalPMRTPMTSchy7GFIb4gTo3xModMlsZhbnXo0OQjuUHNB-DnVZVQc05YQtoXUKDBKS5nx5cQOsoY0YnwlhjKf5KlpLOeeiEGIdybuZb59MdBErX-GhC3WYOK1qPH5XdadaFzwOFl-ZDzzuJsaHGl8q751-wkMVTR-L-KYJUxedn-CBb53t_KTPD3q4jVtoxao6mu3fvYkejsf3o9Pk4vrkbDS4SHQmgCWgBICqMksKxVPGBWcFWMGLijNrGJiSalJSIkoFaZXpnFlgRZmnzBBdWZVtor1572sT3joTW9l_pE1dK29CFyUFmhMARkWP7s9R3YQYG2Pla-OmqplJSuS3UPktVP4I7eHd396unJpqgf4Z7AE6Bz5cbWb_VMnR8OjorzSZZ1xszecio5oXKSADLh-vTuTtY3F_muXH8jz7AvFgjzs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1718077416</pqid></control><display><type>article</type><title>Synthesis and Biological Evaluation of New Eugenol Mannich Bases as Promising Antifungal Agents</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Abrão, Pedro Henrique O. ; Pizi, Rafael B. ; de Souza, Thiago B. ; Silva, Naiara C. ; Fregnan, Antonio M. ; Silva, Fernanda N. ; Coelho, Luiz Felipe L. ; Malaquias, Luiz Cosme C. ; Dias, Amanda Latercia T. ; Dias, Danielle F. ; Veloso, Marcia P. ; Carvalho, Diogo T.</creator><creatorcontrib>Abrão, Pedro Henrique O. ; Pizi, Rafael B. ; de Souza, Thiago B. ; Silva, Naiara C. ; Fregnan, Antonio M. ; Silva, Fernanda N. ; Coelho, Luiz Felipe L. ; Malaquias, Luiz Cosme C. ; Dias, Amanda Latercia T. ; Dias, Danielle F. ; Veloso, Marcia P. ; Carvalho, Diogo T.</creatorcontrib><description>New Mannich base‐type eugenol derivatives were synthesized and evaluated for their anticandidal activity using a broth microdilution assay. Among the synthesized compounds, 4‐allyl‐2‐methoxy‐6‐(morpholin‐4‐ylmethyl) phenyl benzoate (7) and 4‐{5‐allyl‐2‐[(4‐chlorobenzoyl)oxy]‐3‐methoxybenzyl}morpholin‐4‐ium chloride (8) were found to be the most effective antifungal compounds with low IC50 values, some of them well below those of reference drug fluconazole. The most significant IC50 values were those of 7 against C. glabrata (1.23 μm), C. albicans and C. krusei (both 0.63 μm). Additionally, the synthesized compounds were evaluated for their in vitro cytotoxic effects on human mononuclear cells. As result, the cytotoxic activity of eugenol in eukaryotic cells decreased with the introduction of the morpholinyl group. Given these findings, we point out compounds 7 and 8 as the most promising derivatives because they showed potency values greater than those of eugenol and fluconazole and they also presented high selectivity indexes. A series of new eugenol derivatives was synthesized and evaluated for its anticandidal activities. The morpholinyl Mannich base 7 (4‐allyl‐2‐methoxy‐6‐(morpholin‐4‐ylmethyl) phenyl benzoate) showed high antifungal activity (IC50 0.63 μm) and an expressive selectivity index (600.0) against Candida albicans and Candida krusei.</description><identifier>ISSN: 1747-0277</identifier><identifier>EISSN: 1747-0285</identifier><identifier>DOI: 10.1111/cbdd.12504</identifier><identifier>PMID: 25556966</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>antifungal action ; Antifungal Agents - chemical synthesis ; Antifungal Agents - chemistry ; Antifungal Agents - pharmacology ; antimicrobial agents ; Candida - growth &amp; development ; Candida sp ; Candidiasis - drug therapy ; Cytotoxins - chemical synthesis ; Cytotoxins - chemistry ; Cytotoxins - pharmacology ; eugenol ; Eugenol - chemistry ; Eugenol - pharmacology ; Humans ; Leukocytes, Mononuclear - cytology ; Leukocytes, Mononuclear - metabolism ; mannich bases</subject><ispartof>Chemical biology &amp; drug design, 2015-10, Vol.86 (4), p.459-465</ispartof><rights>2014 John Wiley &amp; Sons A/S</rights><rights>2014 John Wiley &amp; Sons A/S.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3674-7a677ad3f09a524565497f659d54fe47eb1c0b106ba72d3c84f749b824e0cdfa3</citedby><cites>FETCH-LOGICAL-c3674-7a677ad3f09a524565497f659d54fe47eb1c0b106ba72d3c84f749b824e0cdfa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fcbdd.12504$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fcbdd.12504$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25556966$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abrão, Pedro Henrique O.</creatorcontrib><creatorcontrib>Pizi, Rafael B.</creatorcontrib><creatorcontrib>de Souza, Thiago B.</creatorcontrib><creatorcontrib>Silva, Naiara C.</creatorcontrib><creatorcontrib>Fregnan, Antonio M.</creatorcontrib><creatorcontrib>Silva, Fernanda N.</creatorcontrib><creatorcontrib>Coelho, Luiz Felipe L.</creatorcontrib><creatorcontrib>Malaquias, Luiz Cosme C.</creatorcontrib><creatorcontrib>Dias, Amanda Latercia T.</creatorcontrib><creatorcontrib>Dias, Danielle F.</creatorcontrib><creatorcontrib>Veloso, Marcia P.</creatorcontrib><creatorcontrib>Carvalho, Diogo T.</creatorcontrib><title>Synthesis and Biological Evaluation of New Eugenol Mannich Bases as Promising Antifungal Agents</title><title>Chemical biology &amp; drug design</title><addtitle>Chem Biol Drug Des</addtitle><description>New Mannich base‐type eugenol derivatives were synthesized and evaluated for their anticandidal activity using a broth microdilution assay. Among the synthesized compounds, 4‐allyl‐2‐methoxy‐6‐(morpholin‐4‐ylmethyl) phenyl benzoate (7) and 4‐{5‐allyl‐2‐[(4‐chlorobenzoyl)oxy]‐3‐methoxybenzyl}morpholin‐4‐ium chloride (8) were found to be the most effective antifungal compounds with low IC50 values, some of them well below those of reference drug fluconazole. The most significant IC50 values were those of 7 against C. glabrata (1.23 μm), C. albicans and C. krusei (both 0.63 μm). Additionally, the synthesized compounds were evaluated for their in vitro cytotoxic effects on human mononuclear cells. As result, the cytotoxic activity of eugenol in eukaryotic cells decreased with the introduction of the morpholinyl group. Given these findings, we point out compounds 7 and 8 as the most promising derivatives because they showed potency values greater than those of eugenol and fluconazole and they also presented high selectivity indexes. A series of new eugenol derivatives was synthesized and evaluated for its anticandidal activities. The morpholinyl Mannich base 7 (4‐allyl‐2‐methoxy‐6‐(morpholin‐4‐ylmethyl) phenyl benzoate) showed high antifungal activity (IC50 0.63 μm) and an expressive selectivity index (600.0) against Candida albicans and Candida krusei.</description><subject>antifungal action</subject><subject>Antifungal Agents - chemical synthesis</subject><subject>Antifungal Agents - chemistry</subject><subject>Antifungal Agents - pharmacology</subject><subject>antimicrobial agents</subject><subject>Candida - growth &amp; development</subject><subject>Candida sp</subject><subject>Candidiasis - drug therapy</subject><subject>Cytotoxins - chemical synthesis</subject><subject>Cytotoxins - chemistry</subject><subject>Cytotoxins - pharmacology</subject><subject>eugenol</subject><subject>Eugenol - chemistry</subject><subject>Eugenol - pharmacology</subject><subject>Humans</subject><subject>Leukocytes, Mononuclear - cytology</subject><subject>Leukocytes, Mononuclear - metabolism</subject><subject>mannich bases</subject><issn>1747-0277</issn><issn>1747-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRS0E4r3hA5CXCClgJ7YnWbalPMRTPMTSchy7GFIb4gTo3xModMlsZhbnXo0OQjuUHNB-DnVZVQc05YQtoXUKDBKS5nx5cQOsoY0YnwlhjKf5KlpLOeeiEGIdybuZb59MdBErX-GhC3WYOK1qPH5XdadaFzwOFl-ZDzzuJsaHGl8q751-wkMVTR-L-KYJUxedn-CBb53t_KTPD3q4jVtoxao6mu3fvYkejsf3o9Pk4vrkbDS4SHQmgCWgBICqMksKxVPGBWcFWMGLijNrGJiSalJSIkoFaZXpnFlgRZmnzBBdWZVtor1572sT3joTW9l_pE1dK29CFyUFmhMARkWP7s9R3YQYG2Pla-OmqplJSuS3UPktVP4I7eHd396unJpqgf4Z7AE6Bz5cbWb_VMnR8OjorzSZZ1xszecio5oXKSADLh-vTuTtY3F_muXH8jz7AvFgjzs</recordid><startdate>201510</startdate><enddate>201510</enddate><creator>Abrão, Pedro Henrique O.</creator><creator>Pizi, Rafael B.</creator><creator>de Souza, Thiago B.</creator><creator>Silva, Naiara C.</creator><creator>Fregnan, Antonio M.</creator><creator>Silva, Fernanda N.</creator><creator>Coelho, Luiz Felipe L.</creator><creator>Malaquias, Luiz Cosme C.</creator><creator>Dias, Amanda Latercia T.</creator><creator>Dias, Danielle F.</creator><creator>Veloso, Marcia P.</creator><creator>Carvalho, Diogo T.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201510</creationdate><title>Synthesis and Biological Evaluation of New Eugenol Mannich Bases as Promising Antifungal Agents</title><author>Abrão, Pedro Henrique O. ; Pizi, Rafael B. ; de Souza, Thiago B. ; Silva, Naiara C. ; Fregnan, Antonio M. ; Silva, Fernanda N. ; Coelho, Luiz Felipe L. ; Malaquias, Luiz Cosme C. ; Dias, Amanda Latercia T. ; Dias, Danielle F. ; Veloso, Marcia P. ; Carvalho, Diogo T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3674-7a677ad3f09a524565497f659d54fe47eb1c0b106ba72d3c84f749b824e0cdfa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>antifungal action</topic><topic>Antifungal Agents - chemical synthesis</topic><topic>Antifungal Agents - chemistry</topic><topic>Antifungal Agents - pharmacology</topic><topic>antimicrobial agents</topic><topic>Candida - growth &amp; development</topic><topic>Candida sp</topic><topic>Candidiasis - drug therapy</topic><topic>Cytotoxins - chemical synthesis</topic><topic>Cytotoxins - chemistry</topic><topic>Cytotoxins - pharmacology</topic><topic>eugenol</topic><topic>Eugenol - chemistry</topic><topic>Eugenol - pharmacology</topic><topic>Humans</topic><topic>Leukocytes, Mononuclear - cytology</topic><topic>Leukocytes, Mononuclear - metabolism</topic><topic>mannich bases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abrão, Pedro Henrique O.</creatorcontrib><creatorcontrib>Pizi, Rafael B.</creatorcontrib><creatorcontrib>de Souza, Thiago B.</creatorcontrib><creatorcontrib>Silva, Naiara C.</creatorcontrib><creatorcontrib>Fregnan, Antonio M.</creatorcontrib><creatorcontrib>Silva, Fernanda N.</creatorcontrib><creatorcontrib>Coelho, Luiz Felipe L.</creatorcontrib><creatorcontrib>Malaquias, Luiz Cosme C.</creatorcontrib><creatorcontrib>Dias, Amanda Latercia T.</creatorcontrib><creatorcontrib>Dias, Danielle F.</creatorcontrib><creatorcontrib>Veloso, Marcia P.</creatorcontrib><creatorcontrib>Carvalho, Diogo T.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Chemical biology &amp; drug design</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abrão, Pedro Henrique O.</au><au>Pizi, Rafael B.</au><au>de Souza, Thiago B.</au><au>Silva, Naiara C.</au><au>Fregnan, Antonio M.</au><au>Silva, Fernanda N.</au><au>Coelho, Luiz Felipe L.</au><au>Malaquias, Luiz Cosme C.</au><au>Dias, Amanda Latercia T.</au><au>Dias, Danielle F.</au><au>Veloso, Marcia P.</au><au>Carvalho, Diogo T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and Biological Evaluation of New Eugenol Mannich Bases as Promising Antifungal Agents</atitle><jtitle>Chemical biology &amp; drug design</jtitle><addtitle>Chem Biol Drug Des</addtitle><date>2015-10</date><risdate>2015</risdate><volume>86</volume><issue>4</issue><spage>459</spage><epage>465</epage><pages>459-465</pages><issn>1747-0277</issn><eissn>1747-0285</eissn><abstract>New Mannich base‐type eugenol derivatives were synthesized and evaluated for their anticandidal activity using a broth microdilution assay. Among the synthesized compounds, 4‐allyl‐2‐methoxy‐6‐(morpholin‐4‐ylmethyl) phenyl benzoate (7) and 4‐{5‐allyl‐2‐[(4‐chlorobenzoyl)oxy]‐3‐methoxybenzyl}morpholin‐4‐ium chloride (8) were found to be the most effective antifungal compounds with low IC50 values, some of them well below those of reference drug fluconazole. The most significant IC50 values were those of 7 against C. glabrata (1.23 μm), C. albicans and C. krusei (both 0.63 μm). Additionally, the synthesized compounds were evaluated for their in vitro cytotoxic effects on human mononuclear cells. As result, the cytotoxic activity of eugenol in eukaryotic cells decreased with the introduction of the morpholinyl group. Given these findings, we point out compounds 7 and 8 as the most promising derivatives because they showed potency values greater than those of eugenol and fluconazole and they also presented high selectivity indexes. A series of new eugenol derivatives was synthesized and evaluated for its anticandidal activities. The morpholinyl Mannich base 7 (4‐allyl‐2‐methoxy‐6‐(morpholin‐4‐ylmethyl) phenyl benzoate) showed high antifungal activity (IC50 0.63 μm) and an expressive selectivity index (600.0) against Candida albicans and Candida krusei.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>25556966</pmid><doi>10.1111/cbdd.12504</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1747-0277
ispartof Chemical biology & drug design, 2015-10, Vol.86 (4), p.459-465
issn 1747-0277
1747-0285
language eng
recordid cdi_proquest_miscellaneous_1718077416
source MEDLINE; Wiley Journals
subjects antifungal action
Antifungal Agents - chemical synthesis
Antifungal Agents - chemistry
Antifungal Agents - pharmacology
antimicrobial agents
Candida - growth & development
Candida sp
Candidiasis - drug therapy
Cytotoxins - chemical synthesis
Cytotoxins - chemistry
Cytotoxins - pharmacology
eugenol
Eugenol - chemistry
Eugenol - pharmacology
Humans
Leukocytes, Mononuclear - cytology
Leukocytes, Mononuclear - metabolism
mannich bases
title Synthesis and Biological Evaluation of New Eugenol Mannich Bases as Promising Antifungal Agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T05%3A29%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20Biological%20Evaluation%20of%20New%20Eugenol%20Mannich%20Bases%20as%20Promising%20Antifungal%20Agents&rft.jtitle=Chemical%20biology%20&%20drug%20design&rft.au=Abr%C3%A3o,%20Pedro%20Henrique%20O.&rft.date=2015-10&rft.volume=86&rft.issue=4&rft.spage=459&rft.epage=465&rft.pages=459-465&rft.issn=1747-0277&rft.eissn=1747-0285&rft_id=info:doi/10.1111/cbdd.12504&rft_dat=%3Cproquest_cross%3E1718077416%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1718077416&rft_id=info:pmid/25556966&rfr_iscdi=true